Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Primary nonadherence to statin medications: Survey of patient perspectives.

Tytuł :
Primary nonadherence to statin medications: Survey of patient perspectives.
Autorzy :
Tarn DM; Department of Family Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.
Pletcher MJ; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Tosqui R; Department of Family Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.
Fernandez A; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Tseng CH; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.
Moriconi R; Department of Family Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.
Bell DS; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.
Barrientos M; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Turner JA; Department of Technology, Operations, and Statistics, Stern School of Business, New York University, New York, NY, USA.
Schwartz JB; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Division of Geriatrics, Department of Medicine and Division of Clinical Pharmacology, Departments of Medicine and Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.
Pokaż więcej
Źródło :
Preventive medicine reports [Prev Med Rep] 2021 Mar 10; Vol. 22, pp. 101357. Date of Electronic Publication: 2021 Mar 10 (Print Publication: 2021).
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Original Publication: [New York, NY] : Elsevier Inc., [2014]-
References :
J Manag Care Pharm. 2013 Jun;19(5):367-73. (PMID: 23697474)
J Am Geriatr Soc. 2012 Jun;60(6):1027-36. (PMID: 22646750)
Am J Pharm Benefits. 2010 Apr 26;2(2):111-118. (PMID: 24466385)
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011. (PMID: 18425859)
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350. (PMID: 30423393)
Qual Life Res. 2003 May;12(3):229-38. (PMID: 12769135)
J Am Board Fam Med. 2021 Jan-Feb;34(1):123-131. (PMID: 33452090)
Eur Heart J. 2013 Oct;34(38):2940-8. (PMID: 23907142)
J Gen Intern Med. 2010 Apr;25(4):280-1. (PMID: 20195783)
Pharm World Sci. 2004 Feb;26(1):26-31. (PMID: 15018256)
Eur Heart J. 2020 Jan 1;41(1):111-188. (PMID: 31504418)
Patient Prefer Adherence. 2018 May 07;12:721-731. (PMID: 29765208)
JAMA Intern Med. 2013 Jan 14;173(1):38-43. (PMID: 23403978)
Ann Intern Med. 2014 Apr 1;160(7):441-50. (PMID: 24687067)
Health Serv Res. 2009 Oct;44(5 Pt 1):1640-61. (PMID: 19500161)
Am J Manag Care. 2013 Apr 01;19(4):e133-9. (PMID: 23725451)
Circulation. 2019 Sep 10;140(11):e649-e650. (PMID: 31498691)
Ann Intern Med. 2010 Nov 16;153(10):633-40. (PMID: 21079218)
J Gen Intern Med. 2012 Jan;27(1):57-64. (PMID: 21879374)
J Am Heart Assoc. 2019 Apr 2;8(7):e011765. (PMID: 30913959)
ACP J Club. 2002 Mar-Apr;136(2):A11-4. (PMID: 11874303)
PLoS One. 2016 Aug 24;11(8):e0160540. (PMID: 27556929)
J Gen Intern Med. 2010 Apr;25(4):284-90. (PMID: 20131023)
J Manag Care Spec Pharm. 2018 Aug;24(8):778-794. (PMID: 30058985)
JAMA Cardiol. 2018 Aug 1;3(8):739-748. (PMID: 29898219)
Patient Prefer Adherence. 2010 Jul 21;4:187-95. (PMID: 20694180)
Am J Manag Care. 2012 Aug;18(8):426-34. (PMID: 22928758)
J Gen Intern Med. 2012 Oct;27(10):1361-7. (PMID: 22618581)
Health Expect. 2011 Sep;14(3):307-20. (PMID: 20860775)
Am J Med. 2011 Nov;124(11):1081.e9-22. (PMID: 22017787)
Health Policy. 2013 Oct;112(3):255-63. (PMID: 23711633)
Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011. (PMID: 25412402)
Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004249. (PMID: 29545393)
JAMA. 2016 Nov 15;316(19):2008-2024. (PMID: 27838722)
PLoS One. 2019 Jan 17;14(1):e0201196. (PMID: 30653535)
JAMA Cardiol. 2019 Mar 1;4(3):206-213. (PMID: 30758506)
BMJ. 2010 Oct 14;341:c5146. (PMID: 20947577)
J Gen Intern Med. 2007 Jan;22(1):6-12. (PMID: 17351835)
Br J Gen Pract. 2018 Jun;68(671):e408-e419. (PMID: 29784867)
Grant Information :
K24 DK102057 United States DK NIDDK NIH HHS; R21 AG055832 United States AG NIA NIH HHS; UL1 TR001872 United States TR NCATS NIH HHS; UL1 TR001881 United States TR NCATS NIH HHS
Contributed Indexing :
Keywords: Medication adherence; Primary nonadherence; Statins; Surveys and questionnaires
Entry Date(s) :
Date Created: 20210412 Latest Revision: 20210414
Update Code :
20210414
PubMed Central ID :
PMC8020471
DOI :
10.1016/j.pmedr.2021.101357
PMID :
33842201
Czasopismo naukowe
Statin medications reduce cardiovascular events, but many patients never start taking their prescribed statin (primary nonadherence). Limited knowledge exists about the attitudes and beliefs of those with primary nonadherence. In this study, patients with primary nonadherence to statin medications (n = 173) completed a self-administered cross-sectional survey that assessed their attitudes and beliefs related to primary nonadherence and to potential motivators for statin use. Patients were recruited in 2019 from two academic health systems and nationwide internet advertisements. Only 49 of 173 (28.3%) patients with primary nonadherence reported having cardiovascular disease (CVD). Ninety-nine patients (57.2%) never filled their prescription, and 74 (42.8%) filled but never took any statin. Over half failed to initially inform their prescriber they might not take the statin. Patients strongly or somewhat agreed that they desired alternate treatment plans such as diet and/or exercise (n = 134; 77.4%) or natural remedies/dietary supplements (n = 125; 72.3%). Ninety-eight (56.6%) stronglyor somewhat worried about the possibility of statin dependence or addiction. Twenty-seven (15.6%) patients noted that they would not take a statin based solely on CVD risk estimates; 50 (28.9%) selected a CVD risk threshold of >20%; and 23 (13.3%) a threshold of >50% as motivating factors to take statins. Patients with primary nonadherence have attitudes about taking statins based on CVD risk that differ from scientific recommendations, may not tell providers about their hesitation to take statins, and likely prefer alternative initial approaches to cholesterol lowering. Early shared decision-making and assessment of patient attitudes about statins could potentially better align initial approaches for CVD risk reduction.
(© 2021 The Authors. Published by Elsevier Inc.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies